TUG1 and metabolic dysfunction-associated steatotic liver disease: In addition, among 112 HBV‐HCCs, 91 HCV‐HCCs, 112 non‐viral‐HCCs, 76 NAFLD patients, and 91 healthy controls, TUG1 expression was the highest in HBV‐HCCs (Figure 1C).